Furthermore, the splenic CD4+ and CD8+ T cells from the three groups all could not inhibit mouse 4T1 breast cancer cells and even promoted the proliferation of 4T1 cells (Supplementary Fig. 9B and 9D). This evidence concerns the gene CD8A and breast carcinoma.